When doctors withhold dietary treatment options from cardiac patients, they are violating the cornerstone of medical ethics, informed consent.
Fully Consensual Heart Disease Treatment
Below is an approximation of this video’s audio content. To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video.
When he was a surgeon at the Cleveland Clinic, Dr. Caldwell Esselstyn published a controversial paper in the American Journal of Cardiology. Heart bypass operations carry significant risks, including the potential to cause “further heart damage, stroke, [and] brain dysfunction.” Angioplasty isn’t much better, also carrying “significant mortality and morbidity,” and often doesn’t work, in terms of decreasing risk of subsequent heart attack or death. “So, it seems we have an enormous paradox. The disease that is the leading killer of men and women in Western civilization is largely untreated.” “The benefits [of the invasive procedures] are at best temporary,…with most patients eventually succumbing to their disease.” In cancer we call that palliative care, where we just kind of throw up our hands, throw in the towel, and give up actually trying to treat the disease. So, why does this juggernaut of invasive procedures persist? Well, one reason is that “performing [surgical] interventions has the potential for enormous financial reward.”
That’s considered one of the barriers to the practice of “preventive cardiology”—”adequate return.” Diet and lifestyle interventions “loses money for the physician.” “Although the practice of preventive cardiology is not…as lucrative…,” this article was hoping to nudge cardiologists in that direction by appealing to less tangible benefits.
Another barrier is doctors don’t think patients want it. Physician surveys show that doctors often don’t even bring up diet and lifestyle options, assuming that patients would prefer, for example, to be on cholesterol-lowering drugs every day for the rest of their lives. That may be true for some, but it’s up to the patient to decide.
According to the official AMA Code of Medical Ethics, physicians are supposed to “disclose all relevant medical information to patients.” “The patient’s right [of] self-decision can be effectively exercised only if the patient possesses enough information to enable an informed choice…The physician’s obligation is to present the medical facts accurately to the patient.”
For example, before starting someone at moderate risk on a cholesterol-lowering statin drug, a physician might ideally say something like, “You should know that for [folks in your situation], the number of individuals who must be treated with a statin to prevent one death from a cardiovascular event such as a heart attack or stroke—is generally between 60 and 100, which means that if I treated 60 people in your position, 1 would benefit and 59 would not. As these numbers show, it is important for you to know that most of the people who take a statin will not benefit from doing so and, moreover, that statins can have side effects, such as muscle pain, liver damage, and upset stomach, even in people who do not benefit from the medication. I am giving you this information so that you can weigh the risks and benefits [of drugs versus diet] and then make an informed decision.”
Yet, I mean, how many physicians have these kinds of frank and open discussions with their patients? Non-disclosure of medical information by doctors, that kind of “paternalism,” is supposed to be a thing of the past. Now physicians are supposed to honor informed consent, unless the patient is in a coma or something, and it’s an emergency. But, too many physicians continue to treat their patients as if they were unconscious.
At the end of this long roundtable discussion on angioplasty and stents, the editor-in-chief of the American Journal of Cardiology reminded the participants of an important fact to place it all in context. Atherosclerosis is due to high cholesterol, which is due to poor dietary choices, and so, “If we all existed on a plant-based diet, we would not have [even] needed this discussion.”
Please consider volunteering to help out on the site.
- D. J. Jenkins, C. W. Kendall, D. G. Popovich, E. Vidgen, C. C. Mehling, V. Vuksan, T. P. Ransom, A. V. Rao, R. Rosenberg-Zand, N. Tariq, P. Corey, P. J. Jones, M. Raeini, J. A. Story, E. J. Furumoto, D. R. Illingworth, A. S. Pappu, P. W. Connelly. Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function. Metab. Clin. Exp. 2001 50(4):494 - 503.
- W. P. Castelli. The new pathophysiology of coronary artery disease. The American journal of cardiology 1998 82(10):60 - 65.
- P Christine. Communicating Evidence in Shared Decision Making. Virtual Mentor 2013 15:9-17.
- V. E. Friedewald, W. E. Boden, G. W. Stone, C. W. Yancy, W. C. Roberts. The editor's roundtable: Role of percutaneous coronary intervention and drug-eluting stents in patients with stable coronary heart disease. Am. J. Cardiol. 2011 108(10):1417 - 1425.
- T. E. Kottke, H. Blackburn, M. L. Brekke, L. I. Solberg. The systematic practice of preventive cardiology. The Am. J. Cardiol. 1987 59(6):690 - 694.
- E. Bruckert, D. Pouchain, S. Auboiron, C. Mulet. Cross-analysis of dietary prescriptions and adherence in 356 hypercholesterolaemic patients. Arch Cardiovasc Dis 2012 105(11):557 - 565.
- L. R. Erhardt, F. D. R. Hobbs. A global survey of physicians' perceptions on cholesterol management: The From The Heart study. Int. J. Clin. Pract. 2007 61(7):1078 - 1085.
- P Ray. Withholding information from patients (therapeutic privilege). Report of the council on ethical and judicial affairs CEJA Report 2-A-06.
- AMA. The AMA code of medical ethics' opinion on informing patients about treatment options. Virtual Mentor 2013 15:1.
- C. B. Esselstyn Jr, R. G. Favaloro. Introduction: More than coronary artery disease. The Am. J. of Cardiol. 1998 82(10):5 - 9.
- T. C. Campbell, B. Parpia, J. Chen. Diet, lifestyle, and the etiology of coronary artery disease: The Cornell China study. Am. J. of Cardiol. 1998 82(10):18 - 21.
- N J Stone. A Report of the American College of Cardiology/American Heart Association task force on practice guidelines. ACC/AHA 2013 1-85.
- L. M. Delahanty, D. Hayden, A. Ammerman, D. M. Nathan. Medical nutrition therapy for hypercholesterolemia positively affects patient satisfaction and quality of life outcomes. Ann Behav Med 2002 24(4):269 - 278.
- G. Weidner, S. L. Connor, J. F. Hollis, W. E. Connor. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. The Family Heart Study. Ann. Intern. Med. 1992 117(10):820 - 823.
- C. B. Esselstyn. Foreword: Changing the treatment paradigm for coronary artery disease. Am. J. of Cardiol. Supplement 1998.
Images thanks to National Institutes of Health via Wikimedia.
- alternative medicine
- American Medical Association
- cancer
- cardiovascular disease
- cholesterol
- complementary medicine
- Dr. Caldwell Esselstyn
- heart disease
- LDL cholesterol
- lifestyle medicine
- liver health
- medical profession
- medications
- mortality
- muscle health
- Plant-Based Diets
- side effects
- statins
- stroke
- surgery
- vegans
- vegetarians
Below is an approximation of this video’s audio content. To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video.
When he was a surgeon at the Cleveland Clinic, Dr. Caldwell Esselstyn published a controversial paper in the American Journal of Cardiology. Heart bypass operations carry significant risks, including the potential to cause “further heart damage, stroke, [and] brain dysfunction.” Angioplasty isn’t much better, also carrying “significant mortality and morbidity,” and often doesn’t work, in terms of decreasing risk of subsequent heart attack or death. “So, it seems we have an enormous paradox. The disease that is the leading killer of men and women in Western civilization is largely untreated.” “The benefits [of the invasive procedures] are at best temporary,…with most patients eventually succumbing to their disease.” In cancer we call that palliative care, where we just kind of throw up our hands, throw in the towel, and give up actually trying to treat the disease. So, why does this juggernaut of invasive procedures persist? Well, one reason is that “performing [surgical] interventions has the potential for enormous financial reward.”
That’s considered one of the barriers to the practice of “preventive cardiology”—”adequate return.” Diet and lifestyle interventions “loses money for the physician.” “Although the practice of preventive cardiology is not…as lucrative…,” this article was hoping to nudge cardiologists in that direction by appealing to less tangible benefits.
Another barrier is doctors don’t think patients want it. Physician surveys show that doctors often don’t even bring up diet and lifestyle options, assuming that patients would prefer, for example, to be on cholesterol-lowering drugs every day for the rest of their lives. That may be true for some, but it’s up to the patient to decide.
According to the official AMA Code of Medical Ethics, physicians are supposed to “disclose all relevant medical information to patients.” “The patient’s right [of] self-decision can be effectively exercised only if the patient possesses enough information to enable an informed choice…The physician’s obligation is to present the medical facts accurately to the patient.”
For example, before starting someone at moderate risk on a cholesterol-lowering statin drug, a physician might ideally say something like, “You should know that for [folks in your situation], the number of individuals who must be treated with a statin to prevent one death from a cardiovascular event such as a heart attack or stroke—is generally between 60 and 100, which means that if I treated 60 people in your position, 1 would benefit and 59 would not. As these numbers show, it is important for you to know that most of the people who take a statin will not benefit from doing so and, moreover, that statins can have side effects, such as muscle pain, liver damage, and upset stomach, even in people who do not benefit from the medication. I am giving you this information so that you can weigh the risks and benefits [of drugs versus diet] and then make an informed decision.”
Yet, I mean, how many physicians have these kinds of frank and open discussions with their patients? Non-disclosure of medical information by doctors, that kind of “paternalism,” is supposed to be a thing of the past. Now physicians are supposed to honor informed consent, unless the patient is in a coma or something, and it’s an emergency. But, too many physicians continue to treat their patients as if they were unconscious.
At the end of this long roundtable discussion on angioplasty and stents, the editor-in-chief of the American Journal of Cardiology reminded the participants of an important fact to place it all in context. Atherosclerosis is due to high cholesterol, which is due to poor dietary choices, and so, “If we all existed on a plant-based diet, we would not have [even] needed this discussion.”
Please consider volunteering to help out on the site.
- D. J. Jenkins, C. W. Kendall, D. G. Popovich, E. Vidgen, C. C. Mehling, V. Vuksan, T. P. Ransom, A. V. Rao, R. Rosenberg-Zand, N. Tariq, P. Corey, P. J. Jones, M. Raeini, J. A. Story, E. J. Furumoto, D. R. Illingworth, A. S. Pappu, P. W. Connelly. Effect of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function. Metab. Clin. Exp. 2001 50(4):494 - 503.
- W. P. Castelli. The new pathophysiology of coronary artery disease. The American journal of cardiology 1998 82(10):60 - 65.
- P Christine. Communicating Evidence in Shared Decision Making. Virtual Mentor 2013 15:9-17.
- V. E. Friedewald, W. E. Boden, G. W. Stone, C. W. Yancy, W. C. Roberts. The editor's roundtable: Role of percutaneous coronary intervention and drug-eluting stents in patients with stable coronary heart disease. Am. J. Cardiol. 2011 108(10):1417 - 1425.
- T. E. Kottke, H. Blackburn, M. L. Brekke, L. I. Solberg. The systematic practice of preventive cardiology. The Am. J. Cardiol. 1987 59(6):690 - 694.
- E. Bruckert, D. Pouchain, S. Auboiron, C. Mulet. Cross-analysis of dietary prescriptions and adherence in 356 hypercholesterolaemic patients. Arch Cardiovasc Dis 2012 105(11):557 - 565.
- L. R. Erhardt, F. D. R. Hobbs. A global survey of physicians' perceptions on cholesterol management: The From The Heart study. Int. J. Clin. Pract. 2007 61(7):1078 - 1085.
- P Ray. Withholding information from patients (therapeutic privilege). Report of the council on ethical and judicial affairs CEJA Report 2-A-06.
- AMA. The AMA code of medical ethics' opinion on informing patients about treatment options. Virtual Mentor 2013 15:1.
- C. B. Esselstyn Jr, R. G. Favaloro. Introduction: More than coronary artery disease. The Am. J. of Cardiol. 1998 82(10):5 - 9.
- T. C. Campbell, B. Parpia, J. Chen. Diet, lifestyle, and the etiology of coronary artery disease: The Cornell China study. Am. J. of Cardiol. 1998 82(10):18 - 21.
- N J Stone. A Report of the American College of Cardiology/American Heart Association task force on practice guidelines. ACC/AHA 2013 1-85.
- L. M. Delahanty, D. Hayden, A. Ammerman, D. M. Nathan. Medical nutrition therapy for hypercholesterolemia positively affects patient satisfaction and quality of life outcomes. Ann Behav Med 2002 24(4):269 - 278.
- G. Weidner, S. L. Connor, J. F. Hollis, W. E. Connor. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. The Family Heart Study. Ann. Intern. Med. 1992 117(10):820 - 823.
- C. B. Esselstyn. Foreword: Changing the treatment paradigm for coronary artery disease. Am. J. of Cardiol. Supplement 1998.
Images thanks to National Institutes of Health via Wikimedia.
- alternative medicine
- American Medical Association
- cancer
- cardiovascular disease
- cholesterol
- complementary medicine
- Dr. Caldwell Esselstyn
- heart disease
- LDL cholesterol
- lifestyle medicine
- liver health
- medical profession
- medications
- mortality
- muscle health
- Plant-Based Diets
- side effects
- statins
- stroke
- surgery
- vegans
- vegetarians
Republishing "Fully Consensual Heart Disease Treatment"
You may republish this material online or in print under our Creative Commons licence. You must attribute the article to NutritionFacts.org with a link back to our website in your republication.
If any changes are made to the original text or video, you must indicate, reasonably, what has changed about the article or video.
You may not use our material for commercial purposes.
You may not apply legal terms or technological measures that restrict others from doing anything permitted here.
If you have any questions, please Contact Us
Fully Consensual Heart Disease Treatment
LicenseCreative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Content URLDoctor's Note
The lack of nutrition training in medical school is another barrier. See, for example, my videos Doctors’ Nutritional Ignorance and Doctors Know Less than They Think About Nutrition.
Shockingly, mainstream medical associations actively oppose attempts to educate physicians about clinical nutrition. See my four-part video series:
- Nutrition Education Mandate Introduced for Doctors
- Medical Associations Oppose Bill to Mandate Nutrition Training
- California Medical Association Tries to Kill Nutrition Bill
- Nutrition Bill Doctored in the California Senate
For more on why doctors don’t make more dietary prescriptions, see The Tomato Effect, Lifestyle Medicine: Treating the Cause of Disease, and Convincing Doctors to Embrace Lifestyle Medicine.
Heart disease may be a choice. See Cavities & Coronaries: Our Choice and One in a Thousand: Ending the Heart Disease Epidemic.
If you haven't yet, you can subscribe to our free newsletter. With your subscription, you'll also get notifications for just-released blogs and videos. Check out our information page about our translated resources.